Method of increasing viability of stored erythrocytes by addition of lipoic, dihydrolipoic, 6,8-bisnortetralipoic, or tetranorlipoic acid
US5827643A · kind A · utility
9Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 1995 |
| Grant date | Oct 27, 1998 |
| Priority date | — |
| Expiry date | Nov 8, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01N1/126
- WIPO fieldBasic materials chemistry
- WIPO sectorChemistry
Abstract
A method of improving the properties of liquid stored or cryogenically stored erythrocytes using D,L-.alpha.-lipoic acid and/or enantiomers or derivatives thereof. Treatment with these substances results in improved oxygen release capacity (2,3-DPG), viscoelasticity and erythrocyte aggregability, and increased resistance to membrane peroxidation during storage and damage by the freeze/thaw process.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.